Breaking News Instant updates and real-time market news.

GD

General Dynamics

$171.30

3.92 (2.34%)

, NOC

Northrop Grumman

$268.83

11.28 (4.38%)

15:39
12/10/18
12/10
15:39
12/10/18
15:39

Defense stocks rise as Trump said to commit to $750B budget

Shares of several defense stocks, including Boeing (BA), General Dynamics (GD), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN), are on the rise following a media report saying that President Trump has told the Pentagon to increase the defense budget to $750B. DEFENSE BUDGET BOOST: President Donald Trump has told Defense Secretary Jim Mattis to submit a $750B budget proposal for fiscal 2020, in a reversal from his pledge to cut defense spending, according to Politico, citing two people familiar with the matter. The $750B figure emerged from a meeting at the White House among Trump, Mattis and the Republican chairmen of the House and Senate Armed Services committees, sources said. The budget number represents all national defense spending, including the Pentagon and Department of Energy funding for the nuclear arsenal. Defense funding is still subject to Budget Control Act spending caps, so lawmakers would need to agree to a deal to lift the caps before the Defense Department could realize this new increase, the report added. PRICE ACTION: In afternoon trading, shares of Boeing have gained about 1%, while General Dynamics and Raytheon's stocks have advanced almost 3%. Also higher, shares of Lockheed Martin and Northrop Grumman have jumped about 5%. Other publicly traded companies in the space include BAE Systems (BAESY) and United Technologies (UTX).

GD

General Dynamics

$171.30

3.92 (2.34%)

NOC

Northrop Grumman

$268.83

11.28 (4.38%)

UTX

United Technologies

$119.03

-0.43 (-0.36%)

BAESY

BAE Systems

$0.00

(0.00%)

RTN

Raytheon

$169.99

4.75 (2.87%)

BA

Boeing

$324.33

1.12 (0.35%)

LMT

Lockheed Martin

$297.38

11.96 (4.19%)

  • 19

    Dec

GD General Dynamics
$171.30

3.92 (2.34%)

10/25/18
FBCO
10/25/18
NO CHANGE
Target $216
FBCO
Outperform
General Dynamics price target lowered to $216 from $229 at Credit Suisse
Credit Suisse analyst Robert Spingarn lowered his price target for General Dynamics to $216 from $229 as softer sales and questions on 2019 drive selloff in the shares. The analyst reiterates an Outperform rating on the shares.
10/25/18
WELS
10/25/18
NO CHANGE
Target $210
WELS
Outperform
General Dynamics price target lowered to $210 from $250 at Wells Fargo
Wells Fargo analyst Sam Pearlstein lowered his price target for General Dynamics to $210 from $250 due to the overall multiple compression in defense stocks. The analyst believes the stock's post-Q3 sell-off had several causes, including a slight EPS miss, a lower Aerospace backlog, and downward revenue revisions in three segments. Still, Pearlstein believes General Dynamics' core defense business is positioned for solid growth, while Gulfstream volumes should improve as soon as Q4. He reiterates and Outperform rating on the shares.
10/24/18
STFL
10/24/18
NO CHANGE
Target $200
STFL
Hold
General Dynamics price target lowered to $200 from $210 at Stifel
Stifel analyst Joseph DeNardi lowered his price target for General Dynamics to $200 from $210 following mixed results as revenue guidance softens. The analyst views the supply chain issues affecting General Dynamics as fixable, while demand at Gulfstream and GD's defense business remains healthy. However, General Dynamics is going to be "treated differently by the market relative to its purer-play defense peers when cycle-related selloffs materialize like today," he contends. DeNardi reiterates a Hold rating on the shares.
09/21/18
09/21/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. UBS SAYS BUY AT&T: UBS analyst John Hodulik upgraded AT&T (T) to Buy and raised his price target for the shares to $38 from $33, noting that the stock is trading near all-time low valuations and at its widest valuation gap to Verizon (VZ). The Time Warner transaction and accounting changes "have compounded [other] issues, leading to a loss of visibility for investors," but his work indicates that AT&T will return to EBITDA growth in the second half of 2018, after a 6% decline in the first half, due to growth in Wireless and WarnerMedia as well as slower declines in Entertainment. JPMORGAN GOES TO BULL FROM BEAR ON NOVAVAX: JPMorgan analyst Eric Joseph double upgraded Novavax (NVAX) to Overweight from Underweight saying the risk/reward is favorable into the report of Prepare trial data in Q1 of 2019. The trial is assessing the efficacy of the company's RSV F Vaccine for infants via maternal immunization and the analyst believes the shares can hit a range of $2.00 to $2.25, he told investors. JPMORGAN SUGGESTS BEING SHORT COPART, LONG KAR: JPMorgan analyst Ryan Brinkman downgraded Copart (CPRT) to Underweight and lowered his price target for the shares to $47 from $48. The company reported softer than expected Q4 results this week but trades at "near record multiples" of earnings and EBITDA, Brinkman told investors. The analyst sees a potential pair trade in going long KAR Auction (KAR) shares, and short Copart shares, to capitalize on the "valuation disconnect." LOOP SETS $8.25 TARGET ON HARMONIC: Loop Capital analyst James Kisner initiated Harmonic (HLIT) with a Buy rating and $8.25 price target, saying he believes Harmonic can "drive robust revenue growth on its Cable Edge business as cable operators like Comcast (CMCSA, CMCSK) adopt its virtual CCAP/CMTS solution," and that the company's video business with stabilize. 'DON'T PANIC' OVER DOD PROPOSAL: Morgan Stanley analyst Rajeev Lalwani attributes the underperformance in Defense stocks over the last two days compared to the broader market to heightened concerns around a month old proposal from the Department of Defense to adjust progress and performance payments down to 50% from 80% of cost, which would effectively slow the timing of cash flow receipts closer to when a project is complete. He sees a number of reasons not to panic, mainly because he believes that the Administration will not move forward with a proposal industry-players will paint as being anti-business and anti-defense spending. Publicly-traded defense contractors include General Dynamics (GD), Huntington Ingalls (HII), L3 Technologies (LLL), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
NOC Northrop Grumman
$268.83

11.28 (4.38%)

09/21/18
MSCO
09/21/18
NO CHANGE
MSCO
Morgan Stanley says not to panic over Defense payment proposal
Morgan Stanley analyst Rajeev Lalwani attributes the underperformance in Defense stocks over the last two days compared to the broader market to heightened concerns around a month old proposal from the Department of Defense to adjust progress and performance payments down to 50% from 80% of cost, which would effectively slow the timing of cash flow receipts closer to when a project is complete. He sees a number of reasons not to panic, firstly because he believes that the Administration will not move forward with a proposal industry-players will paint as being anti-business and anti-defense spending. Even if it were to move forward, the proposal primarily impacts cash flow timing, with underlying earnings unchanged and potential offsets evident, Lalwani tells investors. Lastly, while there would be considerable uncertainty around rule implementation, the proposal would create a path to superior cash flows versus today, the analyst added. Companies in the defense contracting space include General Dynamics (GD), Huntington Ingalls (HII), L3 Technologies (LLL), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
10/25/18
WELS
10/25/18
NO CHANGE
Target $340
WELS
Outperform
Northrop Grumman price target lowered to $340 from $360 at Wells Fargo
Wells Fargo analyst Sam Pearlstein lowered his price target for Northrop Grumman to $340 from $360 to reflect multiple contraction across the peer group. The analyst notes that the company's Q3 segment results beat expectations, but the shares sold off for general market weakness and a revised pension outlook that suggests 2019 GAAP EPS estimates were too high. Pearlstein views this as an overreaction as actual pension cash requirements increased only slightly, the company's organic growth outlook remains firm, and margins should be flat to up going forward. He reiterates an Outperform rating on the shares.
10/25/18
BARD
10/25/18
NO CHANGE
Target $394
BARD
Outperform
Northrop Grumman weakness a buying opportunity, says Baird
Baird analyst Peter Arment said the weakness in Northrop Grumman is a buying opportunity as he remains comfortable believing the company should continue to benefit from higher defense funding and the integration of the OA deal. Arment reiterated his Outperform rating and $394 price target on Northrop shares.
UTX United Technologies
$119.03

-0.43 (-0.36%)

11/27/18
JEFF
11/27/18
NO CHANGE
Target $148
JEFF
Buy
Jefferies analysis values United Technologies at $114-$162 per share
Jefferies analyst Sheila Kahyaoglu's sum-of-the-parts analysis values United Technologies at $114-$162 per share with a midpoint of $135. The high end of a sum-of-the-parts valuation does not always materialize and there is an element of cherry picking the peer group, Kahyaoglu tells investors in a research note after United Technologies announced its "well broadcasted intention" to separate into three individual companies. Given the expected 2020 closing for the break-up the analyst views 2019 as a transition year for the company. She keeps a Buy rating on United Technologies with a $148 price target.
11/28/18
MSCO
11/28/18
NO CHANGE
Target $155
MSCO
Overweight
After pullback, Morgan Stanley says United Technologies 'far from broken'
Morgan Stanley analyst Rajeev Lalwani attributes the 4% pullback in United Technologies shares despite the company closing the Rockwell Collins acquisition and announcing a three-way company split to a range of factors, including a "sell the news" reaction, lighter than expected deal accretion, a longer than expected timeline to complete the split and the stock's relatively resilient share performance year-to-date. While he acknowledges that the major catalyst of closing the deal and announcing a company split has occurred, Lalwani still sees a compelling sum of the parts and favorable risk-reward for United Technologies shares, which he views as "far from broken." Additionally, United Technologies' aftermarket, service and replacement focused business model stands out as being more defensive in a more uncertain environment characterized by peak concerns, the analyst tells investors. Lalwani reiterates his Overweight rating on the shares, but lowered his price target to $155 from $160 to account for an update sum of the parts analysis.
11/28/18
DZBN
11/28/18
UPGRADE
DZBN
Hold
United Technologies upgraded to Hold from Sell at DZ Bank
11/28/18
BARD
11/28/18
NO CHANGE
Target $149
BARD
Outperform
United Technologies price target lowered to $149 from $167 at Baird
Baird analyst Peter Arment lowered his price target on United Technologies to $149 from $167 after the company announced it completed its acquisition of Rockwell Collins and will now separate into three companies. The company also gave a 2019 outlook and projected free cash flow would be weaker than expected. The guidance tempered the separation news, but the analyst still sees value longer-term. Arment maintained his Outperform rating on United Technologies shares.
BAESY BAE Systems
$0.00

(0.00%)

11/02/18
FBCO
11/02/18
UPGRADE
FBCO
Outperform
BAE Systems upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Olivier Brochet upgraded BAE Systems to Outperform from Neutral, telling investors in a research note that he is seeing a positive inflexion in BAE's earnings after a decade of broadly flat EPS. Brochet, who raised his price target to 640p from 630p, thinks that the recent sell-off offers an attractive entry point.
11/09/18
RAJA
11/09/18
UPGRADE
RAJA
Market Perform
BAE Systems upgraded to Market Perform from Underperform at Raymond James
Raymond James analyst Harry Breach upgraded BAE Systems to Market Perform saying the recent pullback in the shares is overdone.
12/06/18
UBSW
12/06/18
DOWNGRADE
UBSW
Neutral
BAE Systems downgraded to Neutral from Buy at UBS
UBS downgraded BAE Systems to Neutral and lowered its price target for the shares to 505p from 720p.
06/29/18
JPMS
06/29/18
UPGRADE
JPMS
Neutral
BAE Systems upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst David Perry upgraded BAE Systems to Neutral and raised his price target for the shares to GBP 6.85 from GBP 6.55.
RTN Raytheon
$169.99

4.75 (2.87%)

08/15/18
UBSW
08/15/18
INITIATION
Target $250
UBSW
Buy
Raytheon initiated with a Buy at UBS
UBS analyst Myles Walton initiated coverage of the Aerospace & Defense sector, starting Raytheon with a Buy rating and $250 price target.
05/24/18
STFL
05/24/18
NO CHANGE
Target $65
STFL
Buy
AeroVironment well-positioned to win new Army contract, says Stifel
Separate from AeroVironment's (AVAV) recent Switchblade contract announcement, Stifel analyst Joseph DeNardi highlighted that the Army recently posted a request for information for Switchblade production from FY19-FY26. DeNardi said it is unclear what the likelihood is that AeroVironment continues to be the sole-source Switchblade provider as it has been from FY17-FY19, as he assumes multiple contractors will reply and suspects that offerings presumably from companies like Raytheon (RTN), Textron (TXT) and possibly Lockheed (LMT) will be more mature than they were a few years ago. Still, he is encouraged by the length of the performance period for the new RFI and views AeroVironment as well-positioned to win the competition, DeNardi tells investors. He keeps a Buy rating and $65 price target on the stock.
BA Boeing
$324.33

1.12 (0.35%)

11/29/18
COWN
11/29/18
NO CHANGE
Target $445
COWN
Outperform
Boeing called a Best Idea for 2019 at Cowen
Cowen analyst Cai von Rumohr said Boeing is his number one pick for its continuing "production sweet spot," which is expected to drive cash flow per share to above consensus in 2019. He also said it has a compelling 3-to-1 risk/reward with upside to $445 per share. The analyst reiterated his Outperform rating on Boeing shares.
10/26/18
BERN
10/26/18
NO CHANGE
Target $440
BERN
Outperform
Boeing price target raised to $440 from $426 at Bernstein
Bernstein analyst Douglas Harnad raised his price target on Boeing to $440 from $426 following the company's "strong" Q3 results, telling investors in a research note that the main driver of Q3 was Boeing Commercial Airplanes performance, with margins above his estimates. Harnad does not expect the company's deals on the T-X trainer and the MQ-25 aircraft to derail an otherwise positive story at Boeing, as stock performance is dominated by BCA. Harnad has an Outperform rating on shares.
12/03/18
BARD
12/03/18
NO CHANGE
Target $450
BARD
Outperform
Boeing delivery pace behind guidance, but 2019 set up favorable, says Baird
Baird analyst Peter Arment said based on his proprietary checks, aircraft deliveries from Boeing during November were only up slightly from October. The company now requires roughly 80 deliveries in December to hit its guidance, he estimates. That amount would require a record month and so far, the company has been unable to catch up from previous LEAP engine delays, said Arment, who still reiterated his Outperform rating and $450 price target on Boeing shares given what he views as its favorable set up for 2019.
11/13/18
JEFF
11/13/18
NO CHANGE
Target $420
JEFF
Buy
Boeing deliveries start quarter slow as expected, says Jefferies
In October, Boeing delivered 57 commercial aircraft versus 56 a year ago and the 87 delivered in September 2018, Jefferies analyst Sheila Kahyaoglu tells investors in a research note titled "October Deliveries: Slow Start to the Q as Expected." She notes that October deliveries were 24% of her total Q4 forecast versus the 27% of Q4 deliveries in October of last year. Boeing's deliveries are expected to ramp in November and December as is the typical seasonal pattern, writes Kahyaoglu. She continues to forecast 242 deliveries for Q4 and 810 for the full year. The analyst keeps a Buy rating on Boeing with a $420 price target.
LMT Lockheed Martin
$297.38

11.96 (4.19%)

10/24/18
10/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lockheed Martin (LMT) upgraded to Conviction Buy from Neutral at Goldman Sachs with analyst Noah Poponak raising his price target for the shares to $394 from $391. 2. Paccar (PCAR) upgraded to Overweight from Neutral at Piper Jaffray with analyst Alexander Potter saying Paccar's brands boasted the highest level of brand loyalty in his firm's survey of 743 U.S.-based fleets. 3. Morgan Stanley (MS) upgraded to Outperform from Market Perform at Wells Fargo with analyst Mike Mayo saying this means he now recommends 5 out of 5 of the largest U.S. wholesale banks. 4. 3D Systems (DDD) upgraded to Neutral from Underweight at Piper Jaffray with analyst Troy Jensen saying while Piper's Q3 survey "showed another poor performance" from 3D Systems' resellers, the company's "significant direct sales win" with Align Technology (ALGN) will continue to allow 3D Systems to report "impressive" year-over-year product growth for the next few quarters. 5. Lululemon (LULU) upgraded to Buy from Hold at Canaccord with analyst Camilo Lyon saying he recommends taking advantage of the recent 15% pullback as he believes the risk/reward is now skewed to the upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/24/18
FBCO
10/24/18
NO CHANGE
Target $357
FBCO
Neutral
Lockheed Martin price target lowered to $357 from $368 at Credit Suisse
Credit Suisse analyst Robert Spingarn lowered his price target for Lockheed Martin to $357 from $368 following quarterly results. The analyst reiterates a Neutral rating on the shares.
10/24/18
GSCO
10/24/18
UPGRADE
Target $394
GSCO
Conviction Buy
Lockheed Martin upgraded to Conviction Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Noah Poponak upgraded Lockheed Martin to Buy and added the shares to his firm's Conviction List. He also raised his price target for the shares to $394 from $391.
10/03/18
FBCO
10/03/18
NO CHANGE
Target $368
FBCO
Neutral
Lockheed Martin price target raised to $368 from $340 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Lockheed Martin to $368 from $340 as his in-depth review of both the F-35 program and the broader business suggests that the bear case largely misses the mark. The analyst believes that Aeronautics and MFC will remain Lockheed's growth leaders over the next several years, and expects growth in Aeronautics to slow but remain positive beyond 2020 as rising F-35 sustainment revenues are only partially offset by C-130J headwinds and plateauing F-35 procurement quantities. RMS faces Black Hawk headwinds in the near-term, but growth should pick up in 2020 and beyond, he contends, adding that space should grow modestly in the near-term. The analyst reiterates a Neutral rating on the shares.

TODAY'S FREE FLY STORIES

XONE

ExOne

$7.00

-0.05 (-0.71%)

, ANSS

Ansys

$238.67

3.63 (1.54%)

05:07
11/19/19
11/19
05:07
11/19/19
05:07
Hot Stocks
ExOne announces collaboration with Ansys »

ExOne (XONE) and ANSYS…

XONE

ExOne

$7.00

-0.05 (-0.71%)

ANSS

Ansys

$238.67

3.63 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 02

    Dec

  • 11

    Dec

EIDX

Eidos Therapeutics

$55.16

8.58 (18.42%)

, BBIO

BridgeBio

$29.06

0.8 (2.83%)

05:07
11/19/19
11/19
05:07
11/19/19
05:07
Recommendations
Eidos Therapeutics price target raised to $75 from $55 at Piper Jaffray »

Piper Jaffray analyst…

EIDX

Eidos Therapeutics

$55.16

8.58 (18.42%)

BBIO

BridgeBio

$29.06

0.8 (2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PHAT

Phathom Pharmaceuticals

$24.88

-1.12 (-4.31%)

05:01
11/19/19
11/19
05:01
11/19/19
05:01
Initiation
Phathom Pharmaceuticals initiated  »

Phathom Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEG

Leggett & Platt

$53.54

0.18 (0.34%)

04:59
11/19/19
11/19
04:59
11/19/19
04:59
Downgrade
Leggett & Platt rating change  »

Leggett & Platt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CSL

Carlisle

$161.08

0.12 (0.07%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Carlisle management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

KRP

Kimbell Royalty Partners

$14.18

0.19 (1.36%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Kimbell Royalty Partners management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

SU

Suncor

$31.84

-0.64 (-1.97%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Suncor management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

ASML

ASML

$273.38

-1.35 (-0.49%)

, ERIC

Ericsson

$9.10

-0.04 (-0.44%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
JPMorgan to hold a conference »

Global TMT…

ASML

ASML

$273.38

-1.35 (-0.49%)

ERIC

Ericsson

$9.10

-0.04 (-0.44%)

IMAX

Imax

$20.88

-0.19 (-0.90%)

SIMO

Silicon Motion

$42.65

0.03 (0.07%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 02

    Dec

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 06

    Jan

ACCO

Acco Brands

$9.42

0.035 (0.37%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Acco Brands management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Stephens business services analyst to hold a group luncheon »

Group Luncheon Meeting to…

CSGS

CSG

$57.54

0.54 (0.95%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
CSG management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
General news
Breaking General news story  »

8-Week Bill Announcement…

ADM

Archer Daniels

$42.84

-0.03 (-0.07%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Archer Daniels management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AHT

Ashford Hospitality

$2.70

-0.005 (-0.19%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Ashford Hospitality management to meet with DA Davidson »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AMSF

Amerisafe

$65.49

-0.15 (-0.23%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Amerisafe management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

ESVIF

Ensign Energy

$0.00

(0.00%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Ensign Energy management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

FC

Franklin Covey

$37.20

-0.3 (-0.80%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Franklin Covey management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PSNL

Personalis

$8.89

-0.85 (-8.73%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Personalis management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

SLNG

Stabilis Energy

$0.00

(0.00%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Stabilis Energy management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

DZSI

Dasan Zhone

$7.58

-0.17 (-2.19%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Dasan Zhone management to meet with B. Riley FBR »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Securities Industry & Financial Markets Association to hold annual meeting »

SIFMA Annual Meeting 2019…

EBSB

Meridian Bancorp

$20.04

0.07 (0.35%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Meridian Bancorp management to meet with Compass Point »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Deutsche Bank to hold a conference »

Japan Consumer &…

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Raymond James to hold a conference »

Growth & Value…

CNR

Cornerstone Building Brands

$6.91

-0.015 (-0.22%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Recommendations
Cornerstone Building Brands analyst commentary  »

Cornerstone Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.